CVE detail

CVE-2023-41150 — CVE-2023-41150

Published 2023-09-06 · Modified 2026-06-17 · Vendor f-revocrm · Product f-revocrm · Source nvd

MEDIUM

severity

CVSS-derived band

5.4

CVSS v3

0–10 scale

0.0030

EPSS probability

exploitation probability, 30d

23.0%

EPSS percentile

percentile vs all CVEs

NOT LISTED

CISA KEV

known exploited catalog

Description

F-RevoCRM 7.3 series prior to version7.3.8 contains a cross-site scripting vulnerability. If this vulnerability is exploited, an arbitrary script may be executed on the web browser of the user who is using the product.

Remediation

No vendor-published fix data in our corpus for this CVE. Check the references below or the vendor's PSIRT / security advisories page.

References

cvedb.io · NVD · CISA KEV · FIRST EPSS · vendor advisories (CVE Program List v5). Informational only, no warranty — verify every remediation against the vendor advisory before acting on it. This product uses data from the NVD API but is not endorsed or certified by the NVD, CISA, FIRST.org or any vendor named. CVE® is a registered trademark of The MITRE Corporation.